益诺思

我们为您提供

从非临床到临床

转化的一站式服务

我们的使命

专注研发服务

赋能健康事业

我们的愿景

科技创新的引领者

新药研发的加速器

生命健康的守护人

我们的核心价值观

科学引领质量唯先

诚信敬业合作共赢

研发服务

科学引领，质量为先

药效平台

待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新待更新
药代动力学平台

Ophthalmology platformOphthalmology platformOphthalmology platformOphthalmology platform
毒理学平台

Radioisotope platformRadioisotope platformRadioisotope platformRadioisotope platformRadioisotope platform
生物样本分析平台

Biological sample analysisBiological sample analysisBiological sample analysisBiological sample analysisBiological sample analysis
生物标记物及转化医学平台

Pharmacodynamic research is the evaluation of the novel therapeutic, which not only determines the therapeutic effect of the novel therapeutic, but also clarifies the functional characteristics of the novel therapeutic, reveals the possible mechanism of action, supports the proposed clinical indications, and provides reliable information for clinical trials of new drugs. Completed in accordance with regulatory agencies (FDA & CDE) required in vitro and in vivo pharmacodynamic data in relevant guidelines.
放射性同位素平台

Pharmacodynamic research is the evaluation of the novel therapeutic, which not only determines the therapeutic effect of the novel therapeutic, but also clarifies the functional characteristics of the novel therapeutic, reveals the possible mechanism of action, supports the proposed clinical indications, and provides reliable information for clinical trials of new drugs. Completed in accordance with regulatory agencies (FDA & CDE) required in vitro and in vivo pharmacodynamic data in relevant guidelines.
眼科一体化评价平台

Pharmacodynamic research is the evaluation of the novel therapeutic, which not only determines the therapeutic effect of the novel therapeutic, but also clarifies the functional characteristics of the novel therapeutic, reveals the possible mechanism of action, supports the proposed clinical indications, and provides reliable information for clinical trials of new drugs. Completed in accordance with regulatory agencies (FDA & CDE) required in vitro and in vivo pharmacodynamic data in relevant guidelines.
猴生殖评价技术平台
吸入制剂评价平台

关于我们

科技创新的引领者
新药研发的加速器
生命健康的守护人

我们成立于2010年，是国药集团下属中国医药工业研究总院有限公司的控股子公司。秉承 “科学引领、质量唯先、诚信敬业、合作共赢 ”的核心价值观，以创新促发展、以质量求生存、以信誉赢客户、以管理创效益，我们先后通过NMPA的GLP认证、美国FDA的GLP检查、OECD 成员国荷兰政府的GLP认证，AAALAC 认证及美国病理学会的CAP认证等，是一家专业的提供生物医药非临床研究服务为主的综合研发服务（CRO）企业。业务范围覆盖早期成药性评价、非临床药效学、非临床安全性评价、非临床药代动力学、临床生物样本分析、生物标志物与转化研究等领域。

人才招聘

加入我们的团队

在益诺思，员工有机会充分发挥其才能，针对员工的不同特点，

公司提供“管理通道”和“专业通道”相结合的职业发展双通道。

沪ICP备16028608号-2 沪公网安备 31011502016605号

Information Disclosure Website map